Future work should further examine the effects of GLP-1 receptor agonists, such as semaglutide, on escalation during acquisition of opioid self-administration
Managing side effects during dose increases Gastrointestinal side effects such as nausea, vomiting, and diarrhea are common while taking GLP-1 medication and usually appear during the start of the medication or when the dose is increased
In June of 2021, the FDA approved Wegovy and Ozempic, a drug that mimics a hormone called semaglutide (GLP-1) that helps regulate appetite and food intake, as a weight loss tool for chronic weight management
Alcohol use can cause nausea and gastroesophageal reflux
Do physical activity Doing physical activity will help your body get into its best condition for your surgery
Steven Peacock Doctor of Osteopathy Chief Medical Officer Evan Johnson Physician Assistant Clinical Team Manager Hee Jin Cayetano Physician Assistant Registered Dietitian Kaedi Fehlberg Nurse Practitioner Clinical Team Manager Rae Beltinck Health & Wellness Manager Trace Owens Nurse Practitioner Elizabeth Snow Nurse Practitioner Adina Simonetti Nurse Practitioner Tailored Treatment